Literature DB >> 19218471

Pulse pressure and presence of coronary artery calcification.

Domenico Russo1, Luigi F Morrone, Stefania Brancaccio, Paola Napolitano, Ermanno Salvatore, Rosanna Spadola, Massimo Imbriaco, Cinzia V Russo, Vittorio E Andreucci.   

Abstract

BACKGROUND: Coronary calcification (CAC) is found in early stages of CKD. Pulse pressure (PP) predicts CAC in dialysis patients. This study evaluates the accuracy of PP in predicting CAC in patients not yet on dialysis (CKD patients).
METHODS: CKD patients (n = 388) underwent coronary calcium score (CAC score) and abdominal x-ray (n = 128) for estimating aorta calcification (AAC). Biochemistry and PP were measured every 3 and 6 months in patients with stage 4 to 5 and 2 to 3 CKD, respectively. The accuracy of PP and AAC was assessed by receiver operating characteristics analysis.
RESULTS: PP correlated with CAC score in the whole cohort and in patients with stages 2 to 3 and stages 4 to 5 CKD. PP >60 mmHg predicted CAC score >0 (OR: 2.14; P < 0.001), > or =100 (OR: 2.92; P < 0.001), > or =400 (OR: 6.17; P < 0.001) after multivariable adjustment. Area under the curve (AUC) was 0.626 for CAC score >0, 0.676 for score >100, and 0.746 for score >400. PP >60 mmHg reduced the rate of event-free survival. AAC was found in 58% of patients and correlated with CAC score. AUC was 0.628 for CAC score >0, 0.652 for score >100, 0.831 for score >400.
CONCLUSION: PP may identify CKD patients with subclinical CAC who need further evaluation. Accuracy of PP and AAC is nearly similar in predicting CAC. High PP indicates vessel wall alterations leading to adverse outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19218471      PMCID: PMC2637581          DOI: 10.2215/CJN.02580508

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  37 in total

1.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; G M London
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

Authors:  Paolo Raggi; Amy Boulay; Scott Chasan-Taber; Naseem Amin; Maureen Dillon; Steven K Burke; Glenn M Chertow
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.

Authors:  A Levin; O Djurdjev; B Barrett; E Burgess; E Carlisle; J Ethier; K Jindal; D Mendelssohn; S Tobe; J Singer; C Thompson
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

4.  Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study.

Authors:  Austin G Stack; Wendy E Bloembergen
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

5.  Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats.

Authors:  Nobuo Nagano; Sonoe Miyata; Sachiko Obana; Nami Kobayashi; Megumi Abe; Naoshi Fukushima; Michihito Wada
Journal:  Nephrol Dial Transplant       Date:  2003-06       Impact factor: 5.992

6.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

Authors:  Gérard M London; Alain P Guérin; Sylvain J Marchais; Fabien Métivier; Bruno Pannier; Hasan Adda
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease.

Authors:  Marie Essig; Brigitte Escoubet; Dominique de Zuttere; Françoise Blanchet; Florence Arnoult; Emmanuel Dupuis; Catherine Michel; Françoise Mignon; France Mentre; Christine Clerici; François Vrtovsnik
Journal:  Nephrol Dial Transplant       Date:  2007-08-17       Impact factor: 5.992

9.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.

Authors:  Mario Cozzolino; Adriana S Dusso; Helen Liapis; Jane Finch; Yan Lu; Steven K Burke; Eduardo Slatopolsky
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  13 in total

Review 1.  Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations.

Authors:  Roberta Russo; Biagio Di Iorio; Luca Di Lullo; Domenico Russo
Journal:  J Nephrol       Date:  2018-04-27       Impact factor: 3.902

Review 2.  Noninvasive imaging for assessment of calcification in chronic kidney disease.

Authors:  Cristina Karohl; Luis D'Marco Gascón; Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

3.  Increased preoperative pulse pressure predicts procedural complications and mortality in patients who undergo tibial interventions for critical limb ischemia.

Authors:  Sara L Zettervall; Dominique B Buck; Jeremy D Darling; Vanessa Lee; Marc L Schermerhorn; Raul J Guzman
Journal:  J Vasc Surg       Date:  2015-11-11       Impact factor: 4.268

4.  Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.

Authors:  Kongkiat Chaikriangkrai; Faisal Nabi; John J Mahmarian; Su Min Chang
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-05       Impact factor: 2.357

5.  Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis.

Authors:  Domenico Russo; Salvatore Corrao; Yuri Battaglia; Michele Andreucci; Antonella Caiazza; Angelo Carlomagno; Monica Lamberti; Nicoletta Pezone; Andrea Pota; Luigi Russo; Maurizio Sacco; Bernadette Scognamiglio
Journal:  Kidney Int       Date:  2011-03-30       Impact factor: 10.612

6.  Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis.

Authors:  Saeed R Khan
Journal:  Transl Androl Urol       Date:  2014-09-01

7.  Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis.

Authors:  Biagio Di Iorio; Lucia Di Micco; Dario Bruzzese; Luca Nardone; Luigi Russo; Pietro Formisano; Vittoria D'Esposito; Domenico Russo
Journal:  J Nephrol       Date:  2017-08-23       Impact factor: 3.902

8.  Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.

Authors:  Masaya Sakamoto; Hirofumi Suzuki; Takeshi Hayashi; Hiroyuki Iuchi; Tsuyoshi Isaka; Noriko Sakamoto; Yosuke Kayama; Katsuyoshi Tojo; Michihiro Yoshimura; Kazunori Utsunomiya
Journal:  Cardiovasc Diabetol       Date:  2012-10-03       Impact factor: 9.951

9.  Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report.

Authors:  Hirofumi Suzuki; Masaya Sakamoto; Takeshi Hayashi; Hiroyuki Iuchi; Kennosuke Ohashi; Tsuyoshi Isaka; Noriko Sakamoto; Yosuke Kayama; Katsuyoshi Tojo; Michihiro Yoshimura; Kazunori Utsunomiya
Journal:  Cardiovasc Diabetol       Date:  2013-05-02       Impact factor: 9.951

10.  Abdominal aortic calcification in patients with CKD.

Authors:  Mieke J Peeters; Jan Ajg van den Brand; Arjan D van Zuilen; Yelka Koster; Michiel L Bots; Marc G Vervloet; Peter J Blankestijn; Jack Fm Wetzels
Journal:  J Nephrol       Date:  2016-03-22       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.